Antiplatelet Therapy in Chronic Urticaria

NCT06268470 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Chronic Urticaria

Interventions

DRUG: Desloratadine plus cilostazol and dipyridamole
DRUG: Desloratadine

Sponsor

Chulalongkorn University